Mon, May 15, 2023

Swayampakula Ramakanth Upgraded (TCRT) to Strong Buy and Held Target at $225 on, May 15th, 2023

Swayampakula Ramakanth of HC Wainwright & Co., Upgraded "Alaunos Therapeutics, Inc." (TCRT) to Strong Buy and Held Target at $225 on, May 15th, 2023.

Swayampakula has made no other calls on TCRT in the last 4 months.



There is 1 other peer that has a rating on TCRT. Out of the 1 peers that are also analyzing TCRT, 0 agree with Swayampakula's Rating of Hold.



This is the rating of the analyst that currently disagrees with Swayampakula


  • Yanan Zhu of "Wells Fargo" Initiated at Buy and Held Target at $450 on, Monday, March 27th, 2023